Jinling Pharmaceutical Company Limited (SHE:000919)
China flag China · Delayed Price · Currency is CNY
7.32
+0.02 (0.27%)
Apr 29, 2026, 3:05 PM CST

SHE:000919 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
3,1723,2563,1642,6492,789
Other Revenue
25.7725.0229.5222.1519.62
3,1973,2813,1942,6712,809
Revenue Growth (YoY)
-2.56%2.74%19.58%-4.91%12.18%
Cost of Revenue
2,5312,6762,5572,1422,181
Gross Profit
665.96605.17637.06528.55628.17
Selling, General & Admin
507.86446.73460.88383.48384.3
Research & Development
110.14110.6979.1474.1757.01
Other Operating Expenses
2320.681318.2119.28
Operating Expenses
641579.86556.22477.52458.93
Operating Income
24.9625.3180.8451.03169.24
Interest Expense
-5.21-2.2-1.3-0.26-0.29
Interest & Investment Income
49.3863.9158.1434.9846.4
Currency Exchange Gain (Loss)
0.010.040.020.08-0
Other Non Operating Income (Expenses)
8.41.73-1.07-1.45-1.42
EBT Excluding Unusual Items
77.5488.8136.6384.38213.92
Impairment of Goodwill
-18.05-86.3---45.97
Gain (Loss) on Sale of Investments
-0.1114.39-0.96-27.14-29.95
Gain (Loss) on Sale of Assets
-0.3921.34-0.5661.8351.98
Asset Writedown
-0.91-10.01-0.15--1.56
Other Unusual Items
7.111.813.48.716.38
Pretax Income
65.1940.01148.36127.77194.81
Income Tax Expense
13.922.0519.613.941.88
Earnings From Continuing Operations
51.2917.95128.76113.87152.94
Minority Interest in Earnings
2.6222.46-22.57-8.58-32.31
Net Income
53.9140.41106.19105.28120.63
Net Income to Common
53.9140.41106.19105.28120.63
Net Income Growth
33.42%-61.95%0.87%-12.72%85.19%
Shares Outstanding (Basic)
622593504504504
Shares Outstanding (Diluted)
622593504504504
Shares Change (YoY)
4.95%17.56%0.01%-0.02%-0.01%
EPS (Basic)
0.090.070.210.210.24
EPS (Diluted)
0.090.070.210.210.24
EPS Growth
27.13%-67.63%0.86%-12.70%85.22%
Free Cash Flow
16.34-47.44-25.85-49.05129.26
Free Cash Flow Per Share
0.03-0.08-0.05-0.100.26
Dividend Per Share
0.1000.1000.1000.1000.100
Gross Margin
20.83%18.44%19.95%19.79%22.36%
Operating Margin
0.78%0.77%2.53%1.91%6.02%
Profit Margin
1.69%1.23%3.33%3.94%4.29%
Free Cash Flow Margin
0.51%-1.45%-0.81%-1.84%4.60%
EBITDA
168.35180.06229.81173.57291.14
EBITDA Margin
5.27%5.49%7.20%6.50%10.37%
D&A For EBITDA
143.38154.75148.97122.54121.9
EBIT
24.9625.3180.8451.03169.24
EBIT Margin
0.78%0.77%2.53%1.91%6.02%
Effective Tax Rate
21.32%55.12%13.21%10.88%21.50%
Revenue as Reported
3,1973,2813,1942,6712,809
Source: S&P Global Market Intelligence. Standard template. Financial Sources.